What is Integrity Orthopaedics?
Based in Maple Plain, Minnesota, Integrity Orthopaedics operates at the intersection of advanced engineering and clinical orthopedic care. The company specializes in the development of sophisticated surgical technology designed to enhance procedural outcomes and improve patient recovery times. By focusing on the modernization of traditional orthopedic workflows, the firm provides surgeons with the tools necessary to navigate complex anatomical challenges with greater accuracy and efficiency.
The company's market position is defined by its commitment to innovation in a sector that is increasingly reliant on data-driven surgical planning and robotic-assisted platforms. As a key player in the medical device ecosystem, Integrity Orthopaedics bridges the gap between complex surgical requirements and scalable technological solutions, effectively addressing the evolving needs of hospitals and private surgical centers alike.
How much funding has Integrity Orthopaedics raised?
Integrity Orthopaedics has raised a total of $20.6M across 1 funding round:
Series B
$20.6M
Series B (2024): $20.6M with participation from Piper Sandler
Key Investors in Integrity Orthopaedics
Piper Sandler
Piper Sandler is a prominent investment bank and institutional securities firm that provides comprehensive advisory services, including mergers and acquisitions and capital raising, with a deep focus on the healthcare and medical technology sectors.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Integrity Orthopaedics?
With the recent influx of capital, Integrity Orthopaedics is expected to accelerate its research and development pipeline, focusing on the next generation of surgical instrumentation. The strategic roadmap likely includes scaling commercial operations to penetrate new regional markets and enhancing its existing product suite to maintain a competitive edge in the orthopedic technology space.
Furthermore, the firm will likely prioritize the integration of its technology into broader hospital networks, leveraging its recent funding to support clinical trials and regulatory milestones. As the company matures, the focus will shift toward establishing long-term partnerships with healthcare providers, ensuring that its technological advancements become a standard component of modern orthopedic practice.
